IGF1R and hepatocellular carcinoma: Additionally, it has been shown that YAP–IGF1R signaling plays a vital role in sorafenib resistance and targeting YAP–IGF-1R is an effective measure for treating sorafenib-resistant HCC (Ngo et al., 2021).